TREM2 and Alzheimer disease: In AD, genetic variants reducing TREM2 signaling causes the reduced induction of DAM, which normally surround amyloid plaques and display active phagocytosis and lipid metabolism, with beneficial consequences on synaptic loss, amyloid peptides burden and dystrophic dendrites (Meilandt et al., 2020; Lee et al., 2021).